Vasoactive Intestinal Peptide Receptor 1 (VIPR1) ELISA Kits

VIPR1 encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Zusätzlich bieten wir Ihnen Vasoactive Intestinal Peptide Receptor 1 Antikörper (125) und Vasoactive Intestinal Peptide Receptor 1 Proteine (6) und viele weitere Produktgruppen zu diesem Protein an.

list all ELISA KIts Gen GeneID UniProt
VIPR1 7433 P32241
VIPR1 22354 P97751
VIPR1 24875 P30083
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top Vasoactive Intestinal Peptide Receptor 1 ELISA Kits auf antikoerper-online.de

Showing 7 out of 19 products:

Katalog Nr. Reaktivität Sensitivität Bereich Bilder Menge Anbieter Lieferzeit Preis Details
Ratte 7.8 pg/mL 31.25-2000 pg/mL Typical standard curve 96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$910.56
Details
Maus 7.8 pg/mL 31.25-2000 pg/mL Typical standard curve 96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$910.56
Details
Human 0.054 ng/mL 0.15-10 ng/mL 96 Tests Anmelden zum Anzeigen 13 bis 16 Tage
$736.84
Details
Huhn 0.094 ng/mL 0.156 ng/mL - 10 ng/mL   96 Tests Anmelden zum Anzeigen 11 bis 18 Tage
$731.99
Details
Schwein 0.094 ng/mL 0.156 ng/mL - 10 ng/mL   96 Tests Anmelden zum Anzeigen 11 bis 18 Tage
$731.99
Details
Kaninchen 37.5 pg/mL 62.5 pg/mL - 4000 pg/mL   96 Tests Anmelden zum Anzeigen 11 bis 18 Tage
$731.99
Details
Affe 0.094 ng/mL 0.156 ng/mL - 10 ng/mL   96 Tests Anmelden zum Anzeigen 11 bis 18 Tage
$731.99
Details

Weitere ELISA Kits für Vasoactive Intestinal Peptide Receptor 1 Interaktionspartner

Human Vasoactive Intestinal Peptide Receptor 1 (VIPR1) Interaktionspartner

  1. In vitro-polarized macrophages by GM-CSF (GM-MO), with a proinflammatory profile, expressed higher levels of VIP receptors, vasoactive intestinal polypeptide receptors 1 and 2 (VPAC1 and VPAC2, respectively), than macrophages polarized by M-CSF (M-MO) with anti-inflammatory activities. RA synovial macrophages, according to their GM-CSF-like polarization state, expressed both VPAC1 and VPAC2.

  2. VPAC1 rs9677 CC genotype could be correlated with a reduced response to statin therapy and seems to be involved in diabetes cardiomyopathy in female patients with type 2 diabetes.

  3. The results reveal that more severe inflammation, based on high levels of IL-6, is associated with lower expression of VPAC1 and, conversely, with increased expression of VPAC2.

  4. variations at the 3'UTR of the VPAC-1 gene act synergistically to affect the expression of the luciferase as well as of the GFP reporter genes expressed in HEK293T cells.

  5. These data suggest that VPAC1 overexpression is associated with poorer differentiation of colon cancer, which is likely caused by subsequent EGFR activation in cancer cells.

  6. VIP regulates CFTR membrane expression and function in Calu-3 cells by increasing its interaction with NHERF1 and P-ERM in a VPAC1- and PKCepsilon-dependent manner.

  7. VPAC1 receptor has a role in endotoxemia in peripheral blood mononuclear cells

  8. The overexpression of VPAC1 and VPAC2 receptors and COX-2 in cancer tissue gives them a potential role as targets for diagnosis of prostate cancer.

  9. hree residues play an important role in VPAC1 interaction with the first histidine residue of VIP. These data demonstrate that VIP and PG97-269 bind to distinct domains of VPAC1

  10. The genetic association reported here indicates that VIP/VPAC1 signaling can be a relevant pathway in the pathogenesis of type 2 diabetes in females

  11. silencing of VPAC1 receptor inhibits vasoactive intestinal peptide effects on both EGF receptor and HER2 transactivation and vascular endothelial growth factor secretion in human breast cancer cells

  12. mRNA expression of the VPAC1 receptor was detected in 51% of the tumor specimens, while the incidence of mRNA expression for VPAC2 was 46%.

  13. increased expression in patients with allergic rhinitis

  14. The VIPR1 polymorphism, previously linked to gastrointestinal dysmotility disorders, does not represent a common risk factor for gallstones in the general or in an elderly population.

  15. Moreover, we report the markedly nuclear localization of VPAC(1) receptors in estrogen-dependent (T47D) and independent (MDA-MB-468) human breast cancer cell lines

  16. role of in MicroRNA 525-5p down-modulating VPAC1 expressio

  17. Results indicate that VPAC1, but not VPAC2 or PAC1, up-regulation in macrophages is a common mechanism in response to acute and chronic pro-inflammatory stimuli.

  18. We describe significant upregulation of the SPP1 gene, downregulation of VIPR1, and losses of the VIPR1 gene.

  19. Vasoactive intestinal peptide receptor-1 (VPAC-1) is a novel gene target of the hemolymphopoietic transcription factor Ikaros.

  20. VPAC1 is a cellular neuroendocrine receptor expressed on T cells that actively facilitates productive HIV-1 infection.

Mouse (Murine) Vasoactive Intestinal Peptide Receptor 1 (VIPR1) Interaktionspartner

  1. This study demonstrated that VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.

  2. VPAC1R mRNA expression was significantly decreased 3 days after ischemia induced by bilateral common carotid artery occlusion

  3. Cyclophosphamide-induced cystitis decreased VPAC1 receptor transcript expression in the urothelium of WT (4 h, 48 h, & chronic) & NGF-OE mice.

  4. Data support the notion that both VPAC1 and VPAC2 receptors are dynamically regulated by Ikaros, a master transcriptional regulator for thymocyte differentiation, during early thymic development.

  5. results support that decline in VIP/VPAC local levels may influence survival/apoptosis intracellular set point in NOD acinar cells and their clearance, contributing to gland homeostasis loss in a model of Sjogren's syndrome

  6. Homozygous deletion of VPAC1 resulted in fetal, neonatal, and postweaning death owing to failure to thrive, intestinal obstruction, and hypoglycemia.

  7. VIP enhancement of the severity of dextran sodium sulfate-induced colitis is mediated solely by VPAC1 receptors in mice.

  8. Data describe PACAP, vasoactive intestinal polypeptide, and PAC1, VPAC1, VPAC2 transcripts or protein expression in urothelium and detrusor smooth muscle and lumbosacral dorsal root ganglia in NGF-overexpressing and wildtype mice.

  9. VPAC(1)-R activation aggravates atherosclerotic lesion formation in apolipoprotein E-deficient mice through enhanced inflammatory activity in the vessel wall.

  10. VIP and its receptors (VPAC1, VPAC2) were identified in type II taste cells of the taste bud, and VIP knockout mice exhibit enhanced taste preference to sweet tastants.

  11. In contrast, selective VPAC(1) receptor activation shifts NSPC fate toward granule cell neurogenesis without any trophism.

  12. VPAC1 suggested as mediator of the neuroprotective effects of VIP

  13. VIP modulation of neural crest differentiation is mediated via VPAC1 and high expression of VPAC1 induces differentiation in and decreases tumorigenicity of neuroblastoma cells.

  14. VIP attenuated the experimental acute pancreatitis enzymatically and morphologically by inhibiting proinflammatory cytokine production from monocytes mainly through the VPAC1-R.

  15. In neonatal mice, a defect occurs in the signal transduction mechanism of the VPAC-1 VIP receptor and cortical astrocytes from neonatal brains are dysfunctional.

  16. VIP inhibits beta-amyloid protein (Abeta)-induced neurodegeneration by indirectly inhibiting production of a wide panel of inflammatory and neurotoxic agents by activated microglia cells.

  17. Data show that VIP and its receptors, VPAC1R and VPAC2R, are expressed in hippocampus, cortex, amygdala and hypothalamus which are involved in learned behaviors.

Rabbit Vasoactive Intestinal Peptide Receptor 1 (VIPR1) Interaktionspartner

  1. Implanting vascular bundles into the tissue engineered bone can significantly improve the expression levels of NK1R and VIPR1.

Zebrafish Vasoactive Intestinal Peptide Receptor 1 (VIPR1) Interaktionspartner

  1. signal pathways, transcript distribution, and splice variants are investigated

Pig (Porcine) Vasoactive Intestinal Peptide Receptor 1 (VIPR1) Interaktionspartner

  1. The study confirmed the presence of VPAC1 receptor in the tissues of the porcine female reproductive tract what clearly shows the possibility of influence of vasoactive intestinal polypeptide on the porcine ovary, oviduct and uterus.

Vasoactive Intestinal Peptide Receptor 1 (VIPR1) Antigen-Profil

Beschreibung des Gens

This gene encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Vasoactive intestinal peptide is involved in smooth muscle relaxation, exocrine and endocrine secretion, and water and ion flux in lung and intestinal epithelia. Its actions are effected through integral membrane receptors associated with a guanine nucleotide binding protein which activates adenylate cyclase. Several transcript variants encoding different isoforms have been found for this gene.

Genbezeichner und Symbole assoziert mit VIPR1

  • vasoactive intestinal peptide receptor 1 (VIPR1) Antikörper
  • vasoactive intestinal peptide receptor 1 (Vipr1) Antikörper
  • vasoactive intestinal peptide receptor 1b (vipr1b) Antikörper
  • vasoactive intestinal peptide receptor 1 (vipr1) Antikörper
  • vasoactive intestinal peptide receptor 1 S homeolog (vipr1.S) Antikörper
  • vasoactive intestinal polypeptide receptor (LOC100303683) Antikörper
  • AV071699 Antikörper
  • CVIPR Antikörper
  • hvr1 Antikörper
  • II Antikörper
  • LOC100226500 Antikörper
  • PACAP-R-2 Antikörper
  • PACAP-R2 Antikörper
  • RATVASREC Antikörper
  • rdc1 Antikörper
  • v1rg Antikörper
  • vapc1 Antikörper
  • VASREC Antikörper
  • VIP-R Antikörper
  • VIP-R-1 Antikörper
  • VIP-R1 Antikörper
  • vipr Antikörper
  • vipr1 Antikörper
  • virg Antikörper
  • vpac1 Antikörper
  • vpac1-r Antikörper
  • VPAC1R Antikörper
  • vpcap1 Antikörper
  • VPCAP1R Antikörper

Bezeichner auf Proteinebene für VIPR1

PACAP type II receptor , VIP and PACAP receptor 1 , VIP receptor, type I , pituitary adenylate cyclase activating polypeptide receptor, type II , vasoactive intestinal polypeptide receptor 1 , PACAP-R-2 , PACAP-R2 , VIP receptor subtype 1 , VIP-R-1 , pituitary adenylate cyclase-activating polypeptide type II receptor , Vasopressive intestinal peptide receptor , vasoactive intestinal peptide receptor 1 , vasoactive intestinal polypeptide receptor 1-like , vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide receptor 1 , VPAC1R , vpac1 receptor , vasoactive intestinal polypeptide receptor type 1 , VIP receptor , Vasoactive intestinal polypeptide receptor

GENE ID SPEZIES
7433 Homo sapiens
395329 Gallus gallus
22354 Mus musculus
24875 Rattus norvegicus
460291 Pan troglodytes
477035 Canis lupus familiaris
535858 Bos taurus
100009518 Oryctolagus cuniculus
100226500 Taeniopygia guttata
100396852 Callithrix jacchus
100466268 Ailuropoda melanoleuca
100500782 Ovis aries
100603830 Nomascus leucogenys
503868 Danio rerio
100136671 Oncorhynchus mykiss
100381144 Xenopus laevis
100155402 Sus scrofa
100303683 Meleagris gallopavo
Ausgewählte Anbieter für Vasoactive Intestinal Peptide Receptor 1 (VIPR1) ELISA Kits
Haben Sie etwas anderes gesucht?